British researchers are continuing to collect convalescent plasma to see how it can best be used as a COVID-19 treatment, in spite of disappointing early findings.
NHS Blood and Transplant has announced it is restarting the collection of donated plasma, as it might benefit certain subgroups such as people with low natural antibody levels.
The decision was made together with the UK Department of Health and Social Care, it was announced. Further benefits of the treatment could be revealed from ongoing analysis of data from the RECOVERY and REMAP-CAP trials, in which the convalescent plasma was tested as a treatment.
In addition, international trials are investigating its benefits when given very early in infection, befo...
4 days ago
British researchers are continuing to collect convalescent plasma to see how it can best be used as a COVID-19 treatment, in spite of disappointing early findings.
NHS Blood and Transplant has announced it is restarting the col...
4 days ago
Scientists have reported a possible new way to reduce the risk of graft-versus-host disease (GvHD) after allogenic bone marrow transplant.
The team, from the Medical University of South Carolina, USA, took a close look at a mol...
4 days ago